Evidence map›Paper›PMID 10934261›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2000

Reduction of neuromuscular activity is required for the rescue of motoneurons from naturally occurring cell death by nicotinic-blocking agents.

R W Oppenheim, D Prevette, A D'Costa, S Wang, L J Houenou, J M McIntosh

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 54 citations in OpenAlex.

  1. Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Astrocyte and muscle-derived secreted factors differentially regulate motoneuron survival.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007
    Article
  17. Article
  18. Glycinergic and GABAergic synaptic activity differentially regulate motoneuron survival and skeletal muscle innervation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2005
    Article
  19. Neuromuscular development after the prevention of naturally occurring neuronal death by Bax deletion.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2003
    Article
  20. Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

R W OppenheimDepartment of Neurobiology and Anatomy and the Neuroscience Program, Wake Forest University Medical School, Winston-Salem, North Carolina 27157-1010, USA. roppenhm@wfubmc.edu
D Prevette
A D'Costa
S Wang
L J Houenou
J M McIntosh
Wake Forest University · USUniversity of Utah · US

Funding

Novel Neuronal nAChR-Targeted PeptidesR01MH053631 · NIMH · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2001 to 2011
$3.6M
NOVEL NEURONAL NACHR-TARGETED PEPTIDESR29MH053631 · NIMH · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 1996 to 2000
$107k
CNS-DERIVED TROPHIC AGENTSR01NS031380 · NINDS · WAKE FOREST UNIVERSITY · PI OPPENHEIM, RONALD W · 1993 to 1996
–
NIMH NIH HHS MH 53631NINDS NIH HHS NS 20420NINDS NIH HHS NS 31380
6 · The paper itself

Abstract

Spinal motoneurons (MNs) in the chick embryo undergo programmed cell death coincident with the establishment of nerve-muscle connections and the onset of synaptic transmission at the neuromuscular junction. Chronic treatment of embryos during this period with nicotinic acetylcholine receptor (nAChR)-blocking agents [e.g., curare or alpha-bungarotoxin (alpha-BTX)] prevents the death of MNs. Although this rescue effect has been attributed previously to a peripheral site of action of the nAChR-blocking agents at the neuromuscular junction (NMJ), because nAChRs are expressed in both muscle and spinal cord, it has been suggested that the rescue effect may, in fact, be mediated by a direct central action of nAChR antagonists. By using a variety of different nAChR-blocking agents that target specific muscle or neuronal nAChR subunits, we find that only those agents that act on muscle-type receptors block neuromuscular activity and rescue MNs. However, paralytic, muscular dysgenic mutant chick embryos also exhibit significant increases in MN survival that can be further enhanced by treatment with curare or alpha-BTX, suggesting that muscle paralysis may not be the sole factor involved in MN survival. Taken together, the data presented here support the argument that, in vivo, nAChR antagonists promote the survival of spinal MNs primarily by acting peripherally at the NMJ to inhibit synaptic transmission and reduce or block muscle activity. Although a central action of these agents involving direct perturbations of MN activity may also play a contributory role, further studies are needed to determine more precisely the relative roles of central versus peripheral sites of action in MN rescue.

Indexed as

AnimalsApoptosisBungarotoxinsCell SurvivalChick EmbryoCurareMotor NeuronsMovementMuscle, SkeletalNeuromuscular JunctionNicotinic AntagonistsPeripheral NervesReceptors, NicotinicSpinal CordSynapsesBungarotoxinsCurareNicotinic AntagonistsReceptors, Nicotinic

Identifiers

PMID10934261
PMCPMC6772570
OpenAlexW2154603822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.